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Abstract
Two exons of the human haptoglobin (HP) gene exhibit copy number variation that affects HP 
multimerization and underlies one of the first protein polymorphisms identified in humans. The 
evolutionary origins and medical significance of this polymorphism have been uncertain. Here we 
show that this variation has likely arisen from the recurring reversion of an ancient hominin-
specific duplication of these exons. Though this polymorphism has been largely invisible to 
genome-wide genetic studies to date, we describe a way to analyze it by imputation from SNP 
haplotypes and find among 22,288 individuals that these HP exonic deletions associate with 
reduced LDL and total cholesterol levels. We show that these deletions, and a SNP that affects HP 
expression, are the likely drivers of the strong but complex association of cholesterol levels to 
SNPs near HP. Recurring exonic deletions in the haptoglobin gene likely enhance human health 
by lowering cholesterol levels in the blood.
Introduction
The HP protein binds free hemoglobin and facilitates its removal from the bloodstream1,2. A 
common 1.7 kb copy number variant (CNV) inside the HP gene determines the copy number 
(generally 1 or 2) of a tandem two-exon segment, including sequence that encodes a 
multimerization domain. This CNV is responsible for a striking protein phenotype: HP 
circulates as a dimer in individuals who are homozygous for the HP1 allele (encoding a 
single copy of the multimerization domain), but it forms multimers in individuals with the 
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two-copy HP2 allele3–5 (Fig. 1). HP2 is also a less efficient antioxidant than HP16, and HP2 
is required to make the tight-junction modulator protein, zonulin, which is the pre-processed 
product of HP27. Whether such functional variation contributes to human phenotypes is not 
well understood.
The alleles of HP are further divided into subtypes by nucleotide polymorphisms that cause 
HP to run “Faster” or “Slower” on a protein gel8, hereafter called the “F” and “S” alleles. 
Both F and S segregate on the HP1 background, creating the subtypes HP1F and HP1S. The 
most common form of HP2 contains both alleles (as paralogous sequence variants) and is 
called HP2FS, but a low frequency HP2SS form also exists9. There are no known functional 
differences between the F and S alleles.
Despite the functional importance of haptoglobin – one of the five most abundant proteins in 
blood10 – and the potential functional importance of the common CNV that affects its 
structure, analyzing the association of this CNV to human phenotypes has proven 
challenging, and the CNV’s relationship to GWAS signals near HP has been unclear11. The 
CNV is not in strong linkage disequilibrium (LD) with any individual SNP11, and it has not 
been successfully genotyped with array-based copy number analysis12 or low coverage 
sequencing13. Instead, the polymorphism is generally typed with protein polyacrylamide gel 
electrophoresis14, PCR15, or quantitative PCR16, which has practically restricted the size of 
most association studies. While the HP polymorphism – one of the earliest polymorphisms 
to be discovered in humans – has been analyzed in hundreds of studies for associations to 
many human phenotypes, the limited sample sizes of these studies have provided insufficient 
power to determine whether the common HP CNV, or other nearby genetic variation, 
contributes to genetically complex phenotypes.
Blood cholesterol levels are one of the most important known biomarkers for future health 
and mortality17. A GWAS for cholesterol levels found a definitive signal (p = 3×10−24) at 
markers near HP18, but as at most GWAS-implicated loci, the causal variant(s) explaining 
this association are not known. While the HP protein’s most familiar role is to bind 
hemoglobin, HP also binds cholesterol molecules19–22. We hypothesized that the HP CNV 
might be responsible for the genetic association of cholesterol levels to this locus. To 
investigate this relationship, we had to develop ways to understand a surprisingly complex 
form of structural variation and its relationships to SNPs and haplotypes.
Results
A revised structural history of the haptoglobin gene
The alleles and mutational history of a locus provide a context for understanding whether 
and how the locus generates phenotypic variation. Standard genomics approaches, such as 
LD-based and array-based CNV analyses, have not yet successfully captured structural 
variation in HP11; we sought to determine why standard methods have failed, and to develop 
a new approach.
The long-accepted model of HP structural evolution23 proposed that HP2 arose through non-
homologous recombination between HP1F and HP1S to produce HP2FS. The assumption 
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that HP2 was formed by the fusion of human HP1 alleles arose from the observation that 
non-human great apes lack HP224 and that the left and right copies of the sequence in 
HP2FS share sequence similarities with HP1F and HP1S respectively23. However, the low 
LD between the HP CNV and surrounding SNPs potentially suggests a more complex 
structural history, as has been noted previously25. We first sought to distinguish between the 
two forces that reduce LD between nearby loci: (1) recombination and (2) recurrent 
mutation. If the low LD (of the CNV with flanking SNPs) were caused by frequent 
homologous recombination near the HP CNV region, then SNPs on the left and right sides 
of the structural variation would have low LD to one another. Conversely, if HP structure 
were affected by recurring intra-chromosomal structural mutations (or by non-allelic 
recombination between identical sister chromatids), then low LD between SNPs and the 
CNV might still be accompanied by high LD between SNPs on either side of the CNV.
We used droplet digital PCR (ddPCR)26 to genotype the HP CNV in 264 unrelated 
individuals sampled by the 1000 Genomes Project13, phased the structural alleles onto SNP 
haplotypes using low-coverage sequence data27, and clustered similar SNP haplotypes 
(Methods). We observed that although many pairs of SNPs on opposite sides of the CNV 
were in high LD with each other (r2 >0.95) (Supplementary Fig. 1), copy number of the HP 
exons was not strongly correlated with any SNP on either side (maximum r2 = 0.44 in 
Europeans from 1000 Genomes). Three common SNP haplotypes (denoted A, B and C in 
Figure 2) persisted through the CNV region, yet segregated with both the HP1 and HP2 
forms, a pattern that appears consistent with recurring structural mutations at HP (Fig. 2).
We next sought to determine whether structural mutations at HP involved deletions or 
duplications, by analyzing the nucleotide variation in the CNV region. We classified 27 
haplotypes as one of four conventional subtypes – HP1S, HP1F, HP2FS, and HP2SS – based 
on the known sequence differences23. For HP2 haplotypes, we refer to the left copy of the 
CNV as HP2-Left (which is proximal to the centromere and 5’ on the transcribed RNA) and 
the right copy as HP2-Right (distal to the centromere and 3’ on the transcribed RNA) (Fig. 
3a). Some 42 nucleotide polymorphisms differed among the subtypes of HP (e.g., between 
HP2FS and HP1S) but were consistent for any given subtype (Fig. 3a, Supplementary Fig. 
2). In order to identify ancestral and derived alleles, we compared the human variants of 
each polymorphism to great ape versions of the HP gene, great ape paralogs of HP, and the 
human haptoglobin-related gene (HPR), which lies 2.2 kb downstream and shares 90% 
sequence identity with HP (Fig. 3a, Supplementary Fig. 3, Methods).
This analysis revealed that HP1F and HP2FS-Left (the left copy of the CNV segment on 
HP2FS) share a 300-bp segment containing 30 derived variants that is nearly identical to a 
portion of the human HPR gene. This segment is likely the result of paralogous gene 
conversion, through which a segment of HPR sequence was transferred into the HP gene 
(Fig. 3a, Supplementary Figs. 2–3). This gene conversion is responsible for the “F” 
mutations in HP1F and HP2FS. We believe that this gene conversion event has complicated 
detection of the CNV in genomic studies, since the copy-number-variable sequence can 
appear to arise partly from HP and partly from HPR, and likely explains why CNV data 
resources
12
,
13
 have lacked genotypes for this CNV. Our analysis also identified a highly 
diverged 250-bp region that has 10 fixed differences (between subtypes) including a mix of 
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derived and ancestral alleles in each segment (Fig. 3a, Supplementary Figs. 2–3). We refer to 
this sequence as the “highly diverged region” and call the allele present in HP1S, HP1F and 
HP2-Right “Form R”, and the allele in HP2-Left “Form L”. We confirmed that these 
sequence differences are consistent at the population level by genotyping the boundaries of 
each variable region using ddPCR in DNA from 590 individuals sampled by HapMap28 and 
the 1000 Genomes Project27 (Fig. 3b, Supplementary Fig. 4, Methods).
The sequence differences between the HP subtypes shown in Figure 3 indicate that neither 
modern HP2 subtype (HP2FS nor HP2SS) could be created through the fusion of known 
HP1F and HP1S subtypes in the way that the earlier model23 proposed (Fig. 3c); for the 
earlier model to be true, HP2 would need to have arisen from a fusion of HP1S with a 
hypothetical diverged HP1 allele (containing Form L of the highly diverged region) that no 
longer segregates at an appreciable frequency in human populations. Alternatively, we 
propose that HP2 could be much older than previously thought, allowing these (non-allelic) 
sequences the time to diverge strongly from each other as paralogous sequence variants on 
an HP2 allele. HP2 does have all the sequences required to form HP1 alleles by simple non-
allelic homologous recombination (NAHR) between the two tandem copies of the two-exon 
segment on HP2FS (Fig. 3d).
Flanking SNP haplotypes also suggested that HP2 did not arise from recombination between 
HP1F and HP1S. All HP1F alleles segregate with SNP haplotype B and almost all HP1S 
alleles segregate with SNP haplotype A (Supplementary Fig. 5). If HP2 had been created 
from non-allelic recombination between these two alleles, SNP haplotype B would be 
proximal to HP2 and SNP haplotype A would be distal (Fig. 3c); however, characteristic 
HP2 SNP haplotypes persist across the CNV region and do not appear to involve such 
recombinant haplotypes (Fig. 3d). (See Supplementary Fig. 6 for our complete model of HP 
structural evolution).
An alternative model would be that HP2 is in fact the ancestral allele in humans, and that 
HP1 alleles arose (and may continue to arise) by simple exonic deletions (due to NAHR) on 
an HP2 background. HP2-to-HP1 deletions have been observed at low frequency in the 
somatic and sperm cells of homozygous HP2 individuals29, demonstrating that the HP gene 
is prone to this type of structural mutation.
We sought to use information from long SNP haplotypes to further evaluate the alternative 
hypothesis that HP2-to-HP1 deletions gave rise to the structural variation at HP. If HP2-to-
HP1 deletions occur intra-chromosomally (or between sister chromatids) and are transmitted 
to offspring, then rare HP1 subtypes might segregate on SNP haplotypes that are usually 
associated with common HP2 subtypes. While the short (10 kb) haplotypes immediately 
around HP cluster into a small number of groups (Fig. 2), we found that longer SNP 
haplotypes have much more information and cluster into a larger number of smaller groups 
(Fig. 4). A dendrogram analysis of these longer haplotypes revealed that several common 
HP2FS-flanking SNP haplotypes also contain rare (singleton) HP1S alleles (Fig. 4, 
Methods). Four of these rare HP1S structures segregate with SNP haplotypes that are 
identical to common HP2FS SNP haplotypes for at least 20 kb on either side of the CNV. 
The HP2FS and HP1S alleles from the same SNP haplotype branch also share derived 
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mutations within the CNV region, consistent with shared ancestry (Supplementary Fig. 7). 
These observations indicate that these four HP1S alleles likely result from recent exonic 
deletions that occurred on an earlier HP2 allele. We also identified a SNP haplotype that 
carries the HP2FS allele in 15/16 sampled Africans but had the HP1S allele in 16/16 
sampled Europeans, consistent with a deletion event in an African ancestor whose 
descendants migrated to Europe (Fig. 4). We conclude that HP structural variation reflects a 
combination of ancient and recent deletions that continue to create HP1 alleles from HP2 
alleles.
In order for common HP1 alleles to be derived deletions, HP2 would have to be ancient. The 
HP2 allele has not been observed in non-human primates, prompting the earlier model23 that 
it was a derived, recent30 allele. However, high-coverage genome sequences from ancient 
hominins are now available. We found that the Homo neandertalensis31 and Homo 
denisova32 genomes both have many sequence reads containing the breakpoint sequence that 
is present on HP2 but not on HP1, and that they also contain all other sequences that define 
the HP2FS subtype (Supplementary Table 1). The presence of HP2FS in neandertals, 
denisovans, and both modern and ancient33 African humans (Fig. 3b, Supplementary Table 
1) indicates that HP2 arose prior to the divergence of these hominins 400 to 600 KYA34. (An 
earlier study, which assumed that HP2 was the derived allele, estimated the age of HP2 at 
less than 100 KY30, but this is contradicted by the ancient hominin genome sequences31,32.) 
SNP haplotypes further support the idea that HP2 is an ancient structural form: unlike HP1, 
HP2 segregates on all four common human SNP haplotypes identified at this locus (A, B, C, 
D in Fig. 2).
HP structural alleles can be imputed from SNP haplotypes
It is important to understand how complex, recurring variation contributes to human 
phenotypes. The gene-conversion history and limited LD between the HP CNV and 
surrounding SNPs have made it challenging to study this structural variation. We sought to 
develop a way to integrate HP structural variation into large-scale genetic studies whose 
large sample sizes enable robust analysis of relationships to phenotypes. We hypothesized 
that although HP structural mutations have occurred many times among human ancestors, 
the subset of these mutations that are old and common today might segregate on 
characteristic SNP haplotypes in many different individuals. Indeed, the above analysis of 
highly specific SNP haplotypes showed that such haplotypes usually segregate with a 
characteristic HP structural allele (Fig. 4).
To test this hypothesis, we phased HP structural alleles with SNP haplotypes to create 
reference chromosomes for imputation35–37 (Supplementary Dataset 1). To measure the 
efficacy of imputation (using Beagle35) we implemented a series of leave-one-out trials, in 
each of which we removed an individual’s HP gene structure from the reference panel and 
attempted to infer what structure was present based on the surrounding SNP haplotype and 
the rest of the reference panel (Methods, Supplementary Note). Although no individual SNP 
had “tagged” HP CNV status (HP2 vs. HP1) with high accuracy (maximum r2 = 0.44), we 
were able to impute HP CNV status from multi-SNP haplotypes in both African and 
European population samples with high accuracy (r2 = 0.94 in a European (CEU, IBS, TSI) 
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population sample, r2 = 0.92 in a Yoruba (YRI) sample), using only SNPs present on 
common SNP genotyping arrays (Table 1, Supplementary Tables 2–5, Supplementary Fig. 
8). We believe this result reflects that, despite recurring mutation at HP, most HP1 alleles 
trace back to a few ancient mutations in common ancestors (more-recent deletion events 
likely reduce the efficacy of imputation but are more rare) (Table 1). Our imputation 
approach allows HP structural variation to be incorporated into large genetic studies using 
existing SNP data.
Haptoglobin and blood cholesterol levels
Both total cholesterol levels and LDL cholesterol levels associate strongly (p = 3×10−24 and 
2×10−22, respectively, in a cohort of >100,000 individuals18) with the SNP rs2000999, 
which is within 15 kb of HP. Given that the HP protein binds to multiple types of cholesterol 
molecules19–22 and that the HP1/HP2 difference has at least a modest correlation with this 
SNP (r2 = 0.14), we hypothesized that the recurring structural variation that causes the 
HP1/HP2 difference could be responsible for the association of cholesterol levels to 
variation in this region.
We were able to obtain genome-wide SNP data from 22,288 individuals of European descent 
with cholesterol measurements (Methods, Supplementary Note, Supplementary Table 6). In 
this sample we found that the GWAS index SNP (rs2000999) associated as expected with 
total cholesterol levels (p = 5.15×10−8) and LDL cholesterol levels (p = 1.43×10−7) (Fig. 
5a,b). We used our approach to impute the most likely HP subtypes in each individual’s 
genome. The imputed HP2 state associated with cholesterol phenotypes much more strongly 
(p = 2.8×10−11 for total cholesterol levels and p = 4.3×10−9 for LDL cholesterol levels) than 
any SNP in the HP region did (Fig. 5a,b). Furthermore, in analyses controlling for the 
HP1/HP2 difference, the association at the index SNP was reduced to p = 0.006 for total 
cholesterol levels and to p = 0.004 for LDL cholesterol levels (Fig. 5c,d) (notably, this was 
still a nominally positive association, which we further explore below), while the HP1/HP2 
variant continued to associate more strongly with cholesterol levels (p = 5.95×10−7 to total 
cholesterol levels and p = 2.02×10−5 to LDL cholesterol levels) in analyses controlling for 
the GWAS index SNP (Fig. 5e–f).
Both HP2 subtypes (HP2FS and HP2SS) were associated with increased cholesterol levels 
(Fig. 6a,b). While the HP1F and HP1S subtypes segregate on very different SNP haplotype 
backgrounds (Supplementary Fig. 5), they associated with similar levels of protection from 
elevated cholesterol levels (Fig. 6a,b), further supporting the idea that HP structural variation 
(rather than nearby sequence variation) is the primary driver of the association to these 
structural alleles.
The GWAS index SNP, rs2000999, is located in a strong enhancer sequence for 
hepatocytes38,39 (the primary source of HP), and the derived allele of this variant associates 
with reduced HP expression40,41. Though the above analysis more strongly implicated the 
HP structural variation than this SNP in cholesterol levels, we hypothesized that both the 
CNV and the rs2000999 variant might affect cholesterol levels through their respective 
effects on haptoglobin structure and abundance. The derived rs2000999-A allele is present 
almost exclusively on HP2 haplotypes (D’ = 0.96), so we examined the effect of each 
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rs2000999 allele on the HP2 background. (The LD between rs2000999 and HP subtypes is 
shown in Supplementary Table 7). We found that while all HP2 alleles associated with an 
increase of total and LDL cholesterol levels when compared to HP1 (Fig. 6a,b), the effect 
was modestly enhanced for HP2 alleles with the derived rs2000999-A allele (Fig. 6c,d). 
When we corrected for the effect of rs2000999, HP2 alleles on all European SNP haplotype 
backgrounds (A–C as shown in Fig. 2) associated with similarly elevated cholesterol levels 
(Fig. 6e,f). We believe that the impact of rs2000999 on HP expression explains the residual 
nominal association that is present at this SNP in analyses conditioning on HP1/HP2. The 
imputation efficacy of the HP1/HP2 difference is similar for each SNP haplotype 
background (haplotype A: r2 = 0.93, haplotype B: r2 = 0.95, haplotype C: r2 = 0.95 using 
SNPs on the Illumina Omni2.5 array), indicating that imperfect imputation is unlikely to 
have strongly biased the association toward rs2000999 or any other SNP.
This analysis indicates that the association of cholesterol phenotypes to SNPs near HP 
reflects a complex allelic architecture arising from multiple variants and historical mutations 
(structural and single-nucleotide) at the locus. The status of rs2000999 as the lead (index) 
SNP at this locus likely reflects a combination of (i) a true genetic effect of this SNP arising 
from an effect on HP expression levels and explaining a ~1.49 mg/dl increase in total 
cholesterol; and (ii) partial LD (r2 = 0.14) to a larger effect (2.11 mg/dl increase in total 
cholesterol) arising from HP structural variation that changes the encoded protein 
(Supplementary Table 8).
Discussion
We presented multiple lines of evidence that recurrent deletions in HP2 have created new 
HP1 alleles, a phenomenon which likely explains the low LD between individual SNPs and 
HP1/HP2. We also found that HP is polymorphic for paralogous gene conversion from HPR, 
which has obscured the CNV from analysis by earlier sequencing and array-based CNV 
studies. While recurring deletions and paralogous gene conversion have made studying this 
structural variation historically challenging, we demonstrated that HP subtypes can be 
imputed from SNP haplotypes with high accuracy, an approach that should make it possible 
to resolve longstanding uncertainty about how genetic variation at HP relates to many 
human phenotypes. We used this imputation strategy to study HP variation in 22,288 
individuals and showed that a complex allelic architecture, shaped most strongly by the HP 
CNV and also by a cis-acting expression effect, is likely responsible for the strong 
association of cholesterol levels with 16q22.2 in GWAS18.
Haptoglobin interacts with the APOE protein, which is critical to maintaining low total 
cholesterol and LDL cholesterol levels42. Oxidation of APOE impairs its ability to clear 
plasma lipids43. The HP protein directly binds APOE20,22 and serves as an APOE 
antioxidant20. The HP2 form of the protein is a less efficient antioxidant than HP16, a 
potential mechanism for the association we observe. Decreased HP levels due to rs2000999-
A may have a similar phenotypic effect, but by reducing the level (rather than changing the 
protein structure) of HP. HP2 and rs2000999-A could contribute to increased total and LDL 
cholesterol levels by providing insufficient antioxidant activity for APOE (Figure 7).
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We found that imputation could be used to extend the analysis of a complex CNV locus to 
very large samples (n=22,288) for which SNP data were available. The large sample was 
critical for resolving multiple effects that are in partial LD, and made it possible to 
appreciate (at high levels of significance) effects that were not apparent in an earlier, smaller 
study44. There are currently controversies about the HP CNV’s role in heart disease, cancer, 
malaria, Crohn’s disease, and numerous other human phenotypes. Our approach to imputing 
complex structural alleles, and the imputation resource we make available here 
(Supplementary Dataset 1), should make it possible to resolve these questions in a definitive 
way using large existing SNP data sets. A similar approach might be useful at the hundreds 
of other loci affected by complex and multi-allelic CNVs.
GWAS has identified thousands of genetic variants that associate with genetically complex 
traits. At almost all of these loci the responsible, functional variants have yet to be found, 
and the underlying allelic architectures are unknown. A particularly intriguing question 
involves the extent to which the underlying allelic architectures will turn out to be simple 
(e.g. a single, responsible functional variant) or complex. Haptoglobin appears to offer an 
early example of a locus at which an association signal arises from the combined effects of 
many different common functional alleles, with different kinds of effects – a set of many 
alleles that affect protein structure, and an additional allele that affects expression level. It 
will be interesting and important to understand how widespread such allelic complexity is in 
human biology.
Online Methods
Genotyping HP structural variants
To determine the copy number of the HP CNV and the other structural polymorphisms, we 
used a droplet-based digital PCR method26 to measure copy number at 4 locations 
(boundaries A,B,D,E in Supplementary Fig. 4b). We designed a pair of PCR primers and a 
dual-labeled fluorescence-FRET oligonucleotide probe to the sequence of each HP boundary 
and to a two-copy control locus. Intermediate copy number calls were repeated with 
triplicate measurements. We used a PCR assay for boundary C to verify the consistency of 
this boundary in HP2SS haplotypes. Only individuals predicted to carry the HP2SS 
haplotype based on ddPCR measurements produced an amplicon. A sufficient number of 
assays were designed such that no single incorrect copy number measurement would 
mistakenly identify a diploid subtype pair as another subtype pair (see Supplementary Table 
9). Allelic copy numbers were determined based on a bi-allelic copy number model for each 
sequence boundary (Supplementary Table 9). Hardy-Weinberg Equilibrium of HP subtypes 
(Supplementary Table 10) and faithful transmission of HP subtypes in trios (Supplementary 
Table 11) were verified. One likely 3-copy allele was found as well as two rare mutations 
that interfere with assay amplification (Supplementary Table 12). Phasing confirmation of 
recent deletion alleles was performed with Drop-Phase45, which is further discussed below 
(Supplementary Table 13). Primer sequences are provided in Supplementary Table 14).
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SNP haplotype analysis for HP CNV and subtypes
HP structural variants were phased with SNP haplotypes from the 1,000 Genomes Project 
Phase I data, and was used to show short haplotypes in four common clusters (Fig. 2) and 
longer closely related haplotypes in a dendrogram (Fig. 4). Haplotypes in Figure 2 were 
clustered with the k-means method using upstream SNP haplotypes only. All recent deletion 
alleles (HP1S subtype) as shown in Figure 4 were from individuals who have two standard 
HP2FS SNP haplotypes. Each deletion allele was phased onto the correct SNP haplotype 
using the Drop-Phase technique45, a new method for phasing based on the idea that 
physically linked sequences are more frequently partitioned into the same droplets 
(Supplementary Table 13). HP structural variants were also phased with SNPs from common 
SNP genotyping arrays to evaluate the potential for these variants to be imputed from 
existing GWAS data. Phasing and encoding for the structural alleles are further discussed in 
the Supplementary Note.
Population sequencing in the CNV region
We Sanger sequenced the CNV region of 27 human haplotypes segregating on diverse SNP 
haplotype backgrounds, and the analogous region of four great apes: chimpanzee, bonobo, 
gorilla, and orangutan. Individual human haplotypes were sequenced by targeting a single 
structural allele from HP1/HP2 heterozygotes. Primers for the human HP2 allele target the 
HP2 breakpoint. HP1 haplotypes were obtained with size selection through gel extraction. 
HP1 sequencing primers were designed to be compatible with the chimpanzee, gorilla, and 
orangutan reference genomes and were also used to sequence the corresponding region in 
each great ape. All primer pairs are specific to HP and do not amplify haptoglobin related 
protein (HPR) or primate haptoglobin (HPP). The hg19 reference genome supplied the 
human HPR sequence. The chimpanzee and gorilla HP genes were sequenced in samples 
NS03489 and PR00107 respectively (DNA provided by Coriell Cell Repositories). The 
sequence for the Chimpanzee HPR and HPP genes was supplied by previously sequenced 
clones (GenBank: M84462.1, M84463.1) See Supplementary Figures 2–3 for additional 
great apes and results by sample and see Supplementary Table 14 for primers.
Creating and testing imputation reference panels
We evaluated the efficacy of imputation for the HP CNV as well as HP subtypes (HP1F, 
HP1S, HP2FS, HP2SS) using reference panels composed of experimentally determined HP 
structural alleles and SNPs ascertained the 1000 Genomes Project13 and HapMap28. 
Separate reference panels were created and tested from each of the following SNP datasets: 
Illumina Omni2.5, HapMap3 (Illumina 1M and Affymetrix 6.0), and Illumina 1M and 
Affymetrix 6.0 individually (Table 1, Supplementary Tables 2–5). Separate reference panels 
were created and tested for European and African populations due to differences in SNP 
haplotype backgrounds for HP subtypes (Figure 4). We performed a series of “leave one 
out” trials to evaluate the efficacy of imputation for HP structural variants. See 
Supplementary Note for more information.
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Imputation of HP structural variation into cohorts for cholesterol association study
A reference panel composed of encoded HP structural alleles and SNPs surrounding the 
CNV region from the Illumina OMNI, Illumina 1M, and Affymetrix 6.0 arrays was 
developed and used to impute HP structural variation into cohorts with cholesterol 
information using Beagle (v2.3.1) imputation software. See Supplementary Note for further 
detail.
Association analysis
The association between imputed HP structural variants and the four lipids traits (total 
cholesterol (TC), low-density lipoprotein (LDL), high density lipoprotein (HDL), and 
triglycerides (TRIGS) was performed in 6 studies of 22,288 individuals of European 
ancestry. Each lipid trait was regressed on age and gender, and inverse-normal transformed 
prior to analysis. Linear regression was performed to test the association between imputed 
structural variants or SNPs in the locus and lipid trait, assuming an additive genetic model 
using PLINK46 (v1.07). The imputed HP structural variants and genotypes were analyzed as 
dosages to account for imputation uncertainty, poorly imputed variants discarded 
(INFO<0.4). All analyses were adjusted for 10 study specific principal components. Study 
specific results were combined via inverse-variance fixed effects meta-analysis method 
implemented in METAL47. Sensitivity and specificity phenotype analyses were performed to 
assess the influence of type 2 diabetes (condition or removal of samples) and cholesterol 
lowering/statin medication use (recalculating values, condition or removal of samples). All 
analyses were performed using baseline lipid measurements for cohorts with longitudinal 
follow-up. See Supplementary Figure 8 for HDL and triglyceride association results and the 
Supplementary Note for more information.
Code availability
The following packages were used to analyze data and are publicly available online: Beagle 
(v2.3.1), PLINK (v1.07), SHAPEIT2 (version 2.644), IMPUTE2 (version 2.3), METAL, 
SMARTPCA. The following custom scripts are available upon request: R scripts used to 
format data, to perform linear regression analyses, and to cluster haplotypes in Fig. 2, a 
PYTHON script used to cluster haplotypes in Fig. 4, and PERL scripts used to format data.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. A common CNV in the HP gene is responsible for distinct molecular phenotypes
The HP2 allele contains two additional exons compared to the HP1 allele: exons 3 and 4 are 
analogous to exons 5 and 6 respectively. The boundaries of the CNV are shown with gray 
boxs on the gene diagrams. The HP1 allele contains one copy of sequence in exon 3 
(orange), which encodes the protein multimerization domain, allowing dimers to be formed. 
HP2 has two copies of this multimerization domain, which results in the formation of 
multimers. Exons 4 and 6 (green) contain the F/S mutations responsible for the protein 
running “Faster” or “Slower” on a gel. The long final exon of HP1 and HP2 encodes the beta 
subunit of the protein (blue), whereas the earlier exons encode the alpha subunit (green and 
orange). The alpha and beta subunits are cleaved apart by proteolytic processing after 
translation but are held together by disulfide bonds5. The protein isoform diagrams shown 
here were modeled after those in an earlier publication5.
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Figure 2. SNP haplotypes surrounding HP persist through the CNV region, yet segregate with 
both structural forms of HP
This plot displays the SNP haplotypes (10 kb on each side of the HP CNV) segregating with 
HP1 and HP2 based on an analysis of 264 samples (528 haplotypes). The upstream SNPs are 
proximal to the centromere, while the downstream SNPs are distal to the centromere. Each 
thin horizontal line represents an individual SNP haplotype; similar or identical haplotypes 
are organized into clusters outlined by colored boxes. Note that the size of small clusters has 
been increased for visibility purposes and the number of haplotypes contained in each 
cluster is indicated at the left of the plot. White represents the minor allele and grey indicates 
the major allele across all populations in the analysis (CEU, IBS, TSI, YRI). Haplotypes 
ascertained from West African (HapMap YRI) individuals are indicated with lavender bars 
to the left of the plot, while haplotypes ascertained in European populations (CEU, IBS, 
TSI) are indicated with dark purple bars to the left of the plot. Haplotypes were clustered 
with the k-means method using upstream SNP haplotypes. Similar SNP haplotypes carrying 
different structures are indicated with colored outlines (dark pink, light blue, green, gold) 
and are designated haplotypes A–D. This figure was based on analysis of 1,000 Genomes 
Project samples and data (Methods).
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Figure 3. SNP haplotypes and sequence differences between HP subtypes inform structural 
history
(a) This alignment shows base pair differences between HP structural forms analyzed from 
27 haplotypes. Only the polymorphic bases are depicted. The HP2FS haplotype contains a 
300-bp segment with derived paralogous gene conversion from HPR (lavender) and a 250-bp 
region that is highly diverged between subtypes (green/pink). Each allele of the highly 
diverged region contains a mix of ancestral and derived alleles. The dashes reflect a 2-bp and 
a 7-bp indel; the other sites shown are individual SNPs. The sequence data used to create 
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this alignment are available online (GenBank: KT923758–KT923784). (b) The frequency of 
each HP haplotype in four populations. (c) The earlier model of HP structural evolution 
(interchromosomal non-homologous recombination) would predict the HP1F SNP haplotype 
background (haplotype B) upstream of HP2 and the HP1S SNP haplotype (haplotype A) 
downstream of HP2. Additionally, it would predict Form R of the highly diverged region in 
HP2-Left. However, neither of these predictions was observed in any of the HP2 alleles in 
this study. (d) Both HP1F and HP1S can be created through simple deletions in HP2FS. The 
dashed lines indicate deleted sequence, while the dashed boxes indicate the sequence 
required to create each HP1 haplotype. The deletion model is also consistent with the 
observed SNP haplotype backgrounds surrounding the CNV.
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Figure 4. Lone HP1S structural alleles segregate on common HP2FS SNP haplotypes
SNP haplotype data is shown for three European populations (CEU, IBS, TSI) and one 
African population (YRI) totaling to 528 haplotypes. SNPs on the left half of the plot exist 
to the left of the HP duplication (proximal to the centromere), whereas SNPs on the right 
half of the plot physically reside to the right of the duplication (distal to the centromere). 
Branch points represent markers at which the depicted haplotypes diverge due to mutation 
and/or recombination with other haplotypes. The structures are represented on the leaves in 
order to clarify their relationships to SNP haplotypes, but the CNV and the paralogous gene 
conversion physically reside within the gap at center of the plot. The African individuals are 
identified with a dot after the leaf. Arrows with numbers indicate HP1 alleles segregating 
with the standard HP2 SNP haplotypes for at least 20 kb on both sides of the CNV. The + 
identifies the SNP haplotype branch which carries HP2FS in almost all sampled Africans, 
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but HP1S in all sampled Europeans. This SNP haplotype is identical downstream of the 
CNV and differs by a single nucleotide upstream of the CNV. The X indicates the single 
haplotype observed in this study with apparent recombination in the CNV region (B/A in 
Figure 2). This recombination event appears to be recent because it is identical to standard 
haplotypes for at least 20 kb on either side of the CNV.
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Figure 5. The HP2 allele associates with increased total cholesterol levels and increased LDL 
cholesterol levels
The imputed structural variants and all regional SNPs imputed from 1,000 Genomes are 
shown for this analysis of 22,288 individuals. (a,b) The HP2 variant is the highest regional 
association to both total cholesterol levels (p = 2.79×10−11) and LDL cholesterol levels (p = 
4.3×10−9). (c,d) Conditioning on the HP2 variant causes most of the signal to disappear. (e,f) 
Conditioning on the GWAS index SNP (rs2000999) only has a moderate effect on the 
association.
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Figure 6. The rs2000999-A allele on the HP2 background associated with a greater increase in 
total cholesterol levels and LDL cholesterol levels
(a,b) The regression beta of HP1 and HP2 alleles with total and LDL cholesterol levels is 
shown with the standard error is shown for this analysis of 22,288 individuals. (c,d) The 
regression beta of each allele of rs2000999 with total and LDL cholesterol levels is shown 
with the standard error. (e,f) The regression beta of each HP subtype and total and LDL 
cholesterol levels separated by SNP haplotype background is plotted with the standard error. 
The beta for each HP1 allele was calculated by a comparison with HP2 alleles only, and the 
beta of HP2 alleles was calculated through a comparison with HP1 alleles only (See 
Methods and Supplementary Note).
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Figure 7. A model for the influence of HP genetic polymorphisms on total and LDL cholesterol 
levels
Because HP serves as an antioxidant for bound APOE20,22 and HP1 has greater antioxidant 
activity than HP26, we propose that HP1 alleles (arising from HP2-to-HP1 deletions) lessen 
the oxidative burden on APOE, allowing it to more effectively clear plasma lipids. 
Conversely, the rs2000999-A allele decreases HP expression40,41 and thus antioxidant 
protection for APOE, contributing to elevated cholesterol levels.
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Table 1
Imputation of HP structural features from surrounding SNPs
This table shows the correlation (r2) between HP structural alleles (as identified by direct molecular analysis) 
and predictions from imputation from the SNP haplotypes, using SNPs on the Illumina Omni2.5 array. The 
correlation between each structural feature and the most strongly correlated individual SNP is also displayed. 
The CEU, IBS, and TSI populations were merged into a single European population for this analysis.
Europeans (CEU, TSI, IBS)
Subtype Imputation (r2) Tag SNP (r2)
  HP1S 0.94 0.86 rs217181
  HP1F 0.98 0.83 rs9302635
  HP2FS 0.94 0.40 rs217181
  HP2SS 0.75 0.58 rs34914030
  HP1 vs. HP2 0.94 0.44 rs217181
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